Mike Garrett, Flamingo

Io­n­is col­lab­o­ra­tor Flamin­go is ready to take flight with 3 an­ti­sense drugs in the clin­ic and mys­te­ri­ous RNA in its sights

As the biggest name in an­ti­sense tech­nol­o­gy, Io­n­is has long fo­cused on test­ing the in­ter­play be­tween oligonu­cleotides and RNA for ther­a­peu­tic ef­fect. But one class …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.